arXiv:2606.04494v1 Announce Type: new Abstract: Biomedical agents promise to automate complex biological workflows, yet current systems face two fundamental bottlenecks: bioinformatics tools are highly heterogeneous in interfaces and execution environments, while agent planning still relies on flat prompt-retrieved tool descriptions. As biomedical software ecosystems grow, this coupling between tool coverage and context size leads to tool confusion, unstable planning, and inefficient execution. We introduce BioManus, an MCP-native biomedical agent built on graph-scaffolded planning over struct
The proliferation of bioinformatics tools and the increasing complexity of biological research necessitate more robust and autonomous AI planning systems to overcome current limitations in prompt-based approaches.
This breakthrough addresses fundamental bottlenecks in biomedical agent systems, paving the way for more efficient and reliable automation of complex biological workflows and drug discovery processes.
AI agents in synthetic biology will transition from constrained prompt-based planning to more flexible and stable graph-scaffolded planning, improving their ability to navigate heterogeneous tool environments.
- · Biomedical research institutions
- · Pharmaceutical companies
- · AI agent developers
- · Synthetic biology sector
- · Companies relying on manual biological workflow execution
- · Less adaptable AI planning methodologies
More accurate and faster drug discovery and development processes.
Accelerated innovation in synthetic biology with fewer experimental failures.
Potential for fully automated, self-correcting biological experimental design and execution leading to novel scientific discoveries.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.AI